| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-08 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
3e-07 |
| mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-07 |